NJ Mom Develops Autism Product, Sells Globally for Multitude of Diseases

Press Release (ePRNews.com) - Teaneck, NJ - Feb 24, 2016 - A Mom of an autistic child sought the help of renown Johns Hopkins geneticist/biochemist, Dr. Richard Kelly, to have her son placed on a barrage of supplements to improve his mitochondrial function, a key component to autism and many other diseases.   The child was functioning wonderfully, until the amount of pills became too much for the 8 year-old.   She consulted a pediatric neurologist at Columbia University who insisted she get the child back on the regimen.  The two joined forces and after months of research and development, succeeded in creating a product that once required 40 capsules per day, now down to about 4 sugar-packet-sized sachets.  The new concoction worked wonderfully for her son.

MitoSpectra is now available in highly concentrated capsules and is useful for other neurological diseases including MS, CP, Downs Syndrome, Alzheimer’s, Parkinson’s.

Jeff Mendelsohn, VP, Sales and Marketing

With her pediatric neurologist’s help, they created MitoSpectra, a product based precisely on Dr. Kelly’s formulation, to help children and adults with autism.

MitoSpectra is now available in highly concentrated capsules and is useful for other neurological diseases including MS, CP, Downs Syndrome, Alzheimer’s, Parkinson’s.  Others purchase the product for its anti-aging properties or body building.   

MitoSpectra is made in the USA under strict CGMP guidelines and sold by MitoMedical, LLC.

The Company seeks to expand its marketing efforts and global sales. 

For more information, visit www.mitomedical.com or email jmendelsohn@mitomedical.com

You may also like this  

DISCLAIMER : If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/services/business mentioned and hereby disclaims any content contained in this press release.

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login